Compare C3.ai Inc (AI) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
C3.ai Inc vs Smith & Nephew plc — how do they compare? C3.ai Inc trades at $10.55 (market cap $1.65B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 7.6× C3.ai Inc's market cap, and Smith & Nephew plc pays a 2.65% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | SNN | |
|---|---|---|
Market Cap | $1.65B | $12.54B |
Sector | Technology | Health |
52-Week High | $19.66 | $38.70 |
52-Week Low | $7.76 | $28.73 |
Enterprise Value | $1.08B | $15.57B |
Dividend Yield | — | 2.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
